These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3546776)

  • 1. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Escherichia coli in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1986 Nov; 39(11):3094-109. PubMed ID: 3546776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Klebsiella sp. in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1986 Nov; 39(11):3110-24. PubMed ID: 3469423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nationwide study of the antimicrobial susceptibility of clinical isolates of Proteus group in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1987 Apr; 40(4):823-42. PubMed ID: 3475483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Sep; 43(9):1530-7. PubMed ID: 2262960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro susceptibility of Escherichia coli and Klebsiella sp. to antibiotics].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Apr; 43(4):659-69. PubMed ID: 2199690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Annual changes of sensitivities of Staphylococcus aureus to several antibiotics].
    Kosakai N; Mori M; Shitara M; Kudo M; Morimoto M
    Jpn J Antibiot; 1982 Aug; 35(8):1934-44. PubMed ID: 6961238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Staphylococcus aureus in Japan].
    Igari J; Shitara M; Shitara S; Yoshimoto K; Hayashi Y; Kosakai N
    Jpn J Antibiot; 1988 May; 41(5):485-93. PubMed ID: 3216471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hospital and district differences in susceptibilities to antibiotics of main clinical isolates].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y; Suzuki A; Kudo H; Hayasaka N; Toyoshima S; Yamazaki Y
    Jpn J Antibiot; 1990 Feb; 43(2):362-73. PubMed ID: 2194057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro susceptibilities of clinical isolates of Staphylococcus aureus].
    Igari J; Shimoji K; Uezu N; Nakasone I; Taira K; Kakazu R
    Jpn J Antibiot; 1988 Sep; 41(9):1205-11. PubMed ID: 3241323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
    Abe T; Sato Y; Sei M
    Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole].
    Toyonaga Y; Kurosu Y; Sugita M; Kumagai K; Hori M; Hoshina S; Kurosaka K; Nishiyama H; Shinohara N; Takahashi T; Deguchi K 210 P
    Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental and clinical evaluation of T-1982 (cefbuperazone) in the field of obstetrics and gynecology].
    Ninomiya K; Makino S; Hasegawa Y; Yoshimoto T
    Jpn J Antibiot; 1983 May; 36(5):986-93. PubMed ID: 6352989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility of clinically isolated Haemophilus influenzae to cephamycin antibiotics].
    Deguchi K
    Jpn J Antibiot; 1983 May; 36(5):1103-8. PubMed ID: 6604823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H
    Jpn J Antibiot; 1984 Apr; 37(4):680-722. PubMed ID: 6433064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.